Mimedx (MDXG) Other Operating Expenses (2017 - 2019)
Mimedx recorded quarterly Other Operating Expenses of $2.3 million in Q4 2019, up 202.57% quarter-over-quarter from -$2.3 million in Q3 2019, and up 841.35% year-over-year from $245712.0 in Q4 2018.
Mimedx's Other Operating Expenses history runs 3 years deep, the most recent figure standing at $2.3 million for Q4 2019.
- In Q4 2019, Other Operating Expenses rose 841.35% year-over-year to $2.3 million; the TTM figure through Sep 2020 stood at $2.3 million (up 190.11% YoY), while the FY2020 annual figure was -$8.2 million, changed N/A from the prior year.
- Other Operating Expenses came in at $2.3 million for Q4 2019 at Mimedx, up from -$2.3 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $2.3 million in Q4 2019 to a low of -$2.3 million in Q3 2019.
- A 3-year average of -$240600.0 and a median of -$312000.0 in 2018 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 841.35% in 2019 and fell as far as 2377.78% in 2019.
- Mimedx's Other Operating Expenses stood at -$1.0 million in 2017, then soared by 70.23% to -$312000.0 in 2018, then soared by 841.35% to $2.3 million in 2019.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $2.3 million, -$2.3 million, and -$312000.0 for Q4 2019, Q3 2019, and Q4 2018 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 2.31 Mn |
| Sep 30, 2019 | -2.26 Mn |
| Dec 31, 2018 | -312,000.00 |
| Sep 30, 2018 | 99,000.00 |
| Sep 30, 2017 | -1.05 Mn |